Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Science Translational Medicine|July 4, 2014
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisGernot Kleinberger, Yoshinori Yamanishi, Marc Suárez-Calvet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementiaJesús Garcia Castro, Sara Rubio-Guerra, Kaitlin B Casaletto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJudit Selma-Gonzalez, Sara Rubio-Guerra, Jesús Garcia Castro, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
JAMA Network Open|March 11, 2021
Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical DeteriorationIgnacio Illán-Gala, Neus Falgàs, Adit Friedberg, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2021
Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserveIgnacio Illán-Gala, Kaitlin B Casaletto, Sergi Borrego-Écija, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
JAMA Neurology|July 6, 2021
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down SyndromeAlexandre Bejanin, Maria Florencia Iulita, Eduard Vilaplana, et al.
Science Translational Medicine|July 4, 2014
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisGernot Kleinberger, Yoshinori Yamanishi, Marc Suárez-Calvet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementiaJesús Garcia Castro, Sara Rubio-Guerra, Kaitlin B Casaletto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJudit Selma-Gonzalez, Sara Rubio-Guerra, Jesús Garcia Castro, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
JAMA Network Open|March 11, 2021
Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical DeteriorationIgnacio Illán-Gala, Neus Falgàs, Adit Friedberg, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2021
Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserveIgnacio Illán-Gala, Kaitlin B Casaletto, Sergi Borrego-Écija, et al.
Pageof 25